The International Journal of Biological Markers
Journal highlights
- Impact Factor: 2.3
- Indexed in: Clarivate Analytics (SCIE, Current Contents – Life Sciences, BIOSIS Previews), PubMed: MEDLINE, and Scopus. Please view the Journal Indexing and Metrics JBM page for a full list of impact metrics and abstracting & indexing.
- Publication is subject to payment of an article processing charge (APC)
The International Journal of Biological Markers (IJBM) is a peer-reviewed open access journal which focusses on topics regarding the application of biomarkers in oncology and is dedicated to solid tumors in adult subjects. The clinical scenarios of interests are screening and early diagnosis of cancer, prognostic assessment, prediction of the response to and monitoring of treatment. Please see the Aims and Scope tab for further information.
Submission information
Submissions should be made online at https://mc.manuscriptcentral.com/tijbm.
For more information please visit the Submission Guidelines tab to find out how to submit your research to this journal.
Open access article processing charge (APC) information
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence.
The article processing charge (APC) for this journal is currently 2800 USD.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.
Contact
Please direct any queries to journal.biomarkers@aulss3.veneto.it
The International Journal of Biological Markers (IJBM) is an international, online only, open access, peer-reviewed journal, which publishes original research and critical reviews primarily focused on cancer biomarkers.
IJBM targets advanced topics regarding the application of biomarkers in oncology and is dedicated to solid tumors in adult subjects. The clinical scenarios of interests are screening and early diagnosis of cancer, prognostic assessment, prediction of the response to and monitoring of treatment. The journal is interested in the publication of studies aimed at validation of biomarkers for clinical application.
In addition, IJBM focuses on research areas that facilitate translational research on biomarkers, such as knowledge translation, bio-banking, biostatistics and method validation and standardization.
| Prof. Stefano Indraccolo | University of Padua and Veneto Institute of Oncology IOV-IRCCS, Italy |
| Dr. Massimo Gion | Regional Center for Biomarkers, Italy |
| Dr. Maria Grazia Daidone | National Cancer Institute, Foundation and IRCCS, Italy |
| Prof. Giampietro Gasparini | ASL Roma1, Italy |
| Prof. Emer. Robin Leake | University of Glasgow, United Kingdom |
| Dr. Emilio Bombardieri | Humanitas Gavazzeni Medical Care Center, Italy |
| Prof. Michele De Bortoli | University of Turin, Italy |
| Dr. Elda Tagliabue | National Cancer Institute, Foundation and IRCCS, Italy |
| Dr. Pierluigi Mauri | Institute for Biomedicl Technologies (ITB-CNR), Italy |
| Prof. Giuseppe Madeddu | University of Sassari, Italy |
| Prof. Marco Salvatore | University of Naples Federico II, Italy |
| Dr. Fiorella Guadagni | IRCCS San Raffaele Pisana, Italy |
| Prof. Chiun-Sheng Huang | National Taiwan University Hospital, China |
| Dr. Giorgio Secreto | National Cancer Institute, Foundation and IRCCS, Italy |
| Prof. Binghe Xu | Chinese Academy of Medical Sciences, China |
| Prof. Vivian Barak | Hadassah Medical Center, Israel |
| Dr. Mario Correale | Member of the Board and Treasurer of ELAS, Italy |
| Dr. Ruggero Dittadi | Member of the Board and Vice President of ELAS, Italy |
| Prof. Emer. Mario Plebani | University of Padua, Italy |
| Assoc. Prof. Francesca Cordero | University of Turin, Italy |
| Prof. Stefano Cascinu | San Raffaele Scientific Institute, IRCCS, Italy |
| Prof. Stephen L. Chan | Chinese University of Hong Kong, China |
| Prof. Massimo Falconi | San Raffaele Scientific Institute, IRCCS, Italy |
| Prof Anna E. Lokshin | UPMC Hillman Cancer Center, United States |
| Prof. Tiziano Maggino | Mestre Hospital, Local Health Authority 3, Italy |
| Prof. Paolo Zola | University of Turin, Italy |
| Dr. Leonardo Franz | University of Padova, Italy |
| Prof. Gino Marioni | University of Padua, Italy |
| Prof. Susanna Nuvoli | University of Sassari, Italy |
| Dr. Etsuro Hatano | Kyoto University, Japan |
| Prof. Claudio Tiribelli | Italian Liver Foundation, Italy |
| Dr. Chiara Trevisiol | Veneto Institute of Oncology IOV-IRCCS, Italy |
| Prof. Kevin Spring | Western Sydney University, Australia |
| Prof. Massimo Di Maio | University of Turin, Italy |
| Prof. Maria Planck | Lund University, Sweden |
| Prof. Giorgio Vittorio Scagliotti | University of Turin, Italy |
| Prof. Yi-long Wu | Guangdong General Hospital, China |
| Prof. Simone Mocellin | Veneto Institute of Oncology IOV-IRCCS, Italy |
| Assoc. Prof. Marco Rastrelli | University of Padua, Italy |
| Dr. Aline S.C. Fabricio | Veneto Institute of Oncology IOV-IRCCS, Italy |
| Dr. Valter Gattei | CRO-National Cancer Institute, Italy |
| Dr. Giuseppe Toffoli | CRO-National Cancer Institute, Italy |
| Prof. Theoni Trangas | University of Ioannina, Greece |
| Prof. Manuel Graeber | University of Sydney Brain and Mind Centre, Australia |
| Prof. Paola Cassoni | University of Turin, Italy |
| Prof. Hironobu Sasano | Tohoku University Hospital, Japan |
| Prof. Jennifer Byrne | Kids Research Institute (KRI), Australia |
| Prof. Xichun Hu | Fudan University Shanghai Cancer Center, China |
| Prof. Patrizia Boracchi | University of Milan, Italy |
| Dr. Valter Torri | Mario Negri Institute IRCCS, Italy |
| Prof. Emer. Francesco Boccardo | University of Genoa, Italy |
| Assoc. Prof. Matteo Brunelli | University of Verona, Italy |
| Prof. Dr. Maurizio Colecchia | IRCCS San Raffaele Hospital and Scientific Institute, Italy |
Manuscript submission guidelines can be accessed on Sage Journals.